A carregar...
A feasibility study showing [68]Ga-citrate PET detects prostate cancer
PURPOSE: The management of advanced or recurrent prostate cancer is limited in part by the lack of effective imaging agents. Metabolic changes in prostate cancer have previously been exploited for imaging, culminating in the recent US-FDA approval of [11]C-choline for the detection of subclinical re...
Na minha lista:
| Publicado no: | Mol Imaging Biol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430569/ https://ncbi.nlm.nih.gov/pubmed/27184068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-016-0966-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|